Space Radiation Accelerates Blood Cell Mutations and Raises Cancer Risk in Male Astronauts
New research shows space radiation drives clonal hematopoiesis and hematologic disease in a gene- and sex-specific way, with male mice hardest hit.
Summary
Astronauts face prolonged exposure to cosmic rays and solar radiation, but the long-term blood health consequences have been unclear. This study used male and female mice engineered with mutations in three genes linked to clonal hematopoiesis — a condition where aging blood stem cells with cancer-associated mutations outcompete healthy ones — to test how space-like radiation affects clone growth and survival over 18 months. Space radiation accelerated the expansion of Trp53 and Ppm1d mutant clones but not Tet2 clones. Male mice with Trp53 mutations showed significantly worse survival after radiation, developed blood disorders, and lost the Y chromosome from blood cells — a known aging biomarker. Female mice with the same mutation were largely protected. The findings suggest male astronauts carrying TP53 clonal hematopoiesis mutations may face elevated hematologic disease risk during and after spaceflight.
Detailed Summary
Clonal hematopoiesis (CH) — the age-related process where blood stem cells carrying somatic mutations gradually dominate the bone marrow — is already recognized as a major driver of cardiovascular disease, blood cancers, and accelerated aging on Earth. What happens when astronauts are exposed to the ionizing radiation of deep space is a critical but poorly studied question with direct relevance to long-duration missions and the aging of returning crew members.
Researchers at the University of Virginia and collaborating institutions used murine models carrying mutations in three well-established CH driver genes — Trp53, Ppm1d, and Tet2 — in both male and female mice. Animals were exposed to gamma radiation, simulated solar particle events, or simplified simulated galactic cosmic rays. Clone expansion and long-term health outcomes were tracked across 18 months.
Space radiation significantly accelerated clonal expansion of Trp53 and Ppm1d mutant cells but had no detectable effect on Tet2 clones. Among male mice harboring Trp53 mutations, radiation exposure worsened survival compared to non-irradiated Trp53 mutant controls. These males also developed overt hematologic disease and exhibited loss of the Y chromosome in blood cells — a phenomenon increasingly recognized as an aging and cancer-risk biomarker in men. Crucially, female mice with the same Trp53 mutation did not show this interaction, suggesting a strong sex-specific component to radiation-induced CH progression.
The findings carry meaningful implications for astronaut health screening and mission risk assessment. Male astronauts who harbor TP53 clonal hematopoiesis — detectable via standard blood sequencing — may face disproportionately elevated risk of clone expansion and hematologic malignancy following exposure to the radiation environment of deep space.
Caveats include the animal model design and extrapolation challenges to humans, and the summary is based on the abstract only. Nevertheless, the gene- and sex-specific patterns identified here provide a strong rationale for pre-flight CH screening, particularly in male astronauts, and for developing targeted monitoring protocols for returning crews.
Key Findings
- Space radiation accelerated clonal expansion of Trp53 and Ppm1d mutations but not Tet2 in blood stem cells.
- Male mice with Trp53 mutations showed markedly worse survival after space radiation exposure over 18 months.
- Irradiated male Trp53 mutant mice developed hematologic disease and lost Y chromosomes from blood cells.
- Female mice with Trp53 mutations were largely protected from radiation-induced survival decline.
- Male astronauts with TP53 clonal hematopoiesis may need targeted pre-flight screening and post-flight monitoring.
Methodology
The study used male and female murine models of Trp53-, Ppm1d-, and Tet2-mediated clonal hematopoiesis exposed to gamma radiation, simulated solar particle events, or simplified simulated galactic cosmic rays. Clone dynamics and health outcomes including survival and hematologic disease were tracked longitudinally over 18 months. Both irradiated and non-irradiated mutant and control groups were compared across driver genes and sex.
Study Limitations
This summary is based on the abstract only, as the full text was not available for review. The study was conducted in mice, and direct translation to human astronauts requires validation in human cohorts and real spaceflight data. The radiation simulations, while designed to approximate space environments, may not fully replicate the complex mixed-field radiation of actual deep-space missions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: